H

HLB Inc
KOSDAQ:028300

Watchlist Manager
HLB Inc
KOSDAQ:028300
Watchlist
Price: 62 700 KRW -1.57% Market Closed
Market Cap: ₩8.3T

HLB Inc
Total Current Liabilities

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
|
See Also

HLB Inc
Total Current Liabilities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Total Current Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
H
HLB Inc
KOSDAQ:028300
Total Current Liabilities
₩347.7B
CAGR 3-Years
20%
CAGR 5-Years
29%
CAGR 10-Years
30%
Suheung Co Ltd
KRX:008490
Total Current Liabilities
₩367.2B
CAGR 3-Years
9%
CAGR 5-Years
7%
CAGR 10-Years
11%
SD Biosensor Inc
KRX:137310
Total Current Liabilities
₩176.6B
CAGR 3-Years
-39%
CAGR 5-Years
44%
CAGR 10-Years
N/A
B
BioPlus Co Ltd
KOSDAQ:099430
Total Current Liabilities
₩112.3B
CAGR 3-Years
147%
CAGR 5-Years
105%
CAGR 10-Years
N/A
T
T&L Co Ltd
KOSDAQ:340570
Total Current Liabilities
₩23.7B
CAGR 3-Years
50%
CAGR 5-Years
34%
CAGR 10-Years
N/A
I
Interojo Co Ltd
KOSDAQ:119610
Total Current Liabilities
₩56.8B
CAGR 3-Years
-9%
CAGR 5-Years
1%
CAGR 10-Years
15%
No Stocks Found

HLB Inc
Glance View

Market Cap
8.3T KRW
Industry
Health Care

Nestled in the bustling corridors of international commerce, HLB Inc. stands as a dynamic player in the healthcare logistics and biomedical sector. Over the years, it has carved a pivotal niche through its adept coordination of high-stakes operations that drive the backbone of medical supply chains. At the heart of its operations are innovative solutions that ensure medical products — ranging from essential pharmaceuticals to state-of-the-art medical devices — navigate smoothly from manufacturers to healthcare providers. This meticulous orchestration not only bolsters the efficiency of healthcare delivery but also makes HLB Inc. an indispensable ally in the realm of modern medicine. The company’s revenue model thrives on the intricate balance of logistical prowess and cutting-edge biomedical services. By leveraging strategic partnerships and technology-driven process improvement, HLB Inc. delivers unparalleled value in both time efficiency and cost-effectiveness. Service contracts with healthcare institutions and governmental bodies serve as significant revenue channels, as the company deftly integrates its logistics network with client demand. Simultaneously, its investments in research and development keep HLB Inc. at the forefront of healthcare innovation, providing an array of bespoke solutions that cater to the evolving landscape of healthcare needs. This dual approach not only solidifies its financial performance but also reflects a commitment to advancing the frontiers of healthcare accessibility and reliability.

Intrinsic Value
1 248.64 KRW
Overvaluation 98%
Intrinsic Value
Price ₩62 700
H

See Also

What is HLB Inc's Total Current Liabilities?
Total Current Liabilities
347.7B KRW

Based on the financial report for Dec 31, 2025, HLB Inc's Total Current Liabilities amounts to 347.7B KRW.

What is HLB Inc's Total Current Liabilities growth rate?
Total Current Liabilities CAGR 10Y
30%

Over the last year, the Total Current Liabilities growth was 116%. The average annual Total Current Liabilities growth rates for HLB Inc have been 20% over the past three years , 29% over the past five years , and 30% over the past ten years .

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett